ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,544.59
-0.78%
US Tech 100
19,249.60
-0.11%
Dow Jones
40,665.02
-1.29%
Brent Oil
84.08
-0.48%
Bitcoin
63,989.36
-0.15%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Thruvision Group Plc (THRU) Quote

Thruvision Group Plc

Thruvision Group Plc (THRU)

LSE
17.00
0.00
(0.00%)
Closed July 18 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
17.00
Bid
16.00
Ask
18.00
Volume
0.00
17.00 Day's Range 17.00
15.25 52 Week Range 31.50
Market Cap
27.373M
Previous Close
17.00
Open
17.00
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
76,729
Shares Outstanding
161,015,138
Dividend Yield
-
PE Ratio
-34.00
Earnings Per Share (EPS)
-0.01
Revenue
12.42M
Net Profit
-805k

About Thruvision Group Plc

Sector
Security Systems Service
Industry
Security Systems Service
Website
ww.thruvision.com
Headquarters
Oxon, Gbr
Founded
1970
Thruvision Group Plc is listed in the Security Systems Service sector of the London Stock Exchange with ticker THRU. The last closing price for Thruvision was 17p. Over the last year, Thruvision shares have traded in a share price range of 15.25p to 31.50p.

Thruvision currently has 161,015,138 shares outstanding. The market capitalization of Thruvision is £27.37 million. Thruvision has a price to earnings ratio (PE ratio) of -34.00.

THRU Latest News

More News

EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows

The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not sepa ...

June 28 2024
Alliance News

Thruvision Group PLC Final Results

Thruvision Group PLC 28 June 2024   28 June 2024 Thruvision Group plc   Results for the year ended 31 March 2024   Thruvision (AIM:THRU, 'Thruvision' or the 'Group'), the leading international...

June 28 2024
RNS Regulatory News

Thruvision Group PLC Results notification

Thruvision Group PLC 12 June 2024   12 June 2024 Thruvision Group plc   Results notification   Thruvision Group plc (AIM:THRU, "Thruvision" or the "Group"), the leading international provider...

June 12 2024
RNS Regulatory News

Thruvision Group PLC Holding(s) in Company

Thruvision Group PLC 03 June 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

June 03 2024
RNS Regulatory News

Thruvision Group PLC Holding(s) in Company

Thruvision Group PLC 31 May 2024   Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares:...

May 31 2024
RNS Regulatory News

Thruvision Group PLC Thruvision partners with Sensormatic Solutions

Thruvision Group PLC 30 May 2024   30 May 2024 Thruvision Group plc   Thruvision partners with Sensormatic Solutions to provide next generation of walk-through people security screening...

May 30 2024
RNS Non-Regulatory

Thruvision Group PLC Block listing Interim Review

Thruvision Group PLC 22 May 2024   RNS 22 May 2024 Thruvision Group plc   ("Thruvision" or the "Company")   Blocklisting update   Thruvision (AIM:THRU, "Thruvision" or the "Group"), the...

May 22 2024
RNS Regulatory News

Thruvision Group PLC Block listing Interim Review

Thruvision Group PLC 22 May 2024   RNS 22 May 2024 Thruvision Group plc   ("Thruvision" or the "Company")   Blocklisting update   Thruvision (AIM:THRU, "Thruvision" or the "Group"), the...

May 22 2024
RNS Regulatory News

Thruvision revenue dips; loss widens in line with expectations

Thruvision Group PLC on Friday was optimistic looking ahead, despite reporting a drop in annual revenue. Thruvision ...

April 26 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1001717171500017DE
4001717172202117DE
12-0.5-2.8571428571417.51815.257672916.33046976DE
26-1.75-9.3333333333318.752015.257760417.44835856DE
52-13-43.33333333333031.515.2511133121.42385543DE
156-7.4-30.327868852524.434.515.2512684622.4965479DE
260-11-39.28571428572834.513.513599123.5602192DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 4.36
(65.78%)
2.21M
NVOSNovo Integrated Sciences Inc
$ 0.8094
(34.38%)
6.7M
DRUGBright Minds Biosciences Inc
$ 1.2698
(16.50%)
344.11k
TCTuanChe Ltd
$ 1.79
(15.48%)
40.83k
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2801
(13.86%)
383.5k
KITTNauticus Robotics Inc
$ 0.0999
(-22.50%)
8.67M
ZCMDZhongchao Inc
$ 1.12
(-15.79%)
358
SCHLScholastic Corporation
$ 32.59
(-10.86%)
9.3k
PLUGPlug Power Inc
$ 2.62
(-10.27%)
5.03M
GDTCCytoMed Therapeutics Ltd
$ 2.06
(-10.05%)
4.13k
KITTNauticus Robotics Inc
$ 0.0999
(-22.50%)
8.67M
NVOSNovo Integrated Sciences Inc
$ 0.8094
(34.38%)
6.7M
NVDANVIDIA Corporation
$ 121.77
(0.56%)
5.79M
ONCOOnconetix Inc
$ 0.204
(-6.55%)
5.56M
PLUGPlug Power Inc
$ 2.62
(-10.27%)
5.03M

Discussion

View Full Feed
Mark Mark 2 minutes ago
$SERV hit 4.44 high in A/Hs, nice call.
SERV
Pierrocks Pierrocks 2 minutes ago
I Tarzan you Jane. -Pier
TSOI
gdl gdl 2 minutes ago
6-day event on Nasdaq ONLY. The 3 indices are out of sync. Let's see if that holds. On the political front obviously Trump and his running mate is giving them pause on their party choice to win the election. Add the growing storm and pressure for Biden to exit. that is now likely. he has no s
jay_tee jay_tee 2 minutes ago
I agree. No one gets paid to bash a no bidder especially one that sits on the EM. 99% of people who post do it just because of entertainment! lol 1% actually provide logical, factual, and informative posts. I’m here because of a little logic but mostly entertainment! Lol
RNVA
jsc52033 jsc52033 3 minutes ago
question for the board
DOwn broke down and began to fill the along naked candel, Spy gapped down, Gold looks to be form a cup wwith the beginning of a handle.
Can Spy get back up to test that high for a place short?
SPY
novascotiaSTS novascotiaSTS 3 minutes ago
You don’t need to worry, European investors won’t receive any payments according to AZ because you need to be a US Participating Member

:-)

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171122810
COOP
mike93433 mike93433 4 minutes ago
And it shows in the share price. Hopefully the Investor Talk next week reveals some good news: https://investornews.com/events/investortalk-with-ian-clifford-from-fuelpositive-corporation-tsxv-nhhh-otcqb-nhhhf/
NHHHF
DesktopDR DesktopDR 4 minutes ago
Why did the website address change?
https://www.voip-pal.com was being used until recently
VPLM
Duma Duma 5 minutes ago
Sorry for the shortcut. LOY=low of yesterday. Could have used YL for yesterday low.
NorthPeak22 NorthPeak22 5 minutes ago
Sky Sports Reports Celtic Have Signed Kasper Schmeichel

https://www.inflation.us/content/sky-sports-reports-celtic-have-signed-kasper-schmeichel

Celtic plc (LSE: CCP) or CLTFF has officially signed veteran goalkeeper Kasper Schmeichel to a one-year deal according to Sky
CLTFF
StockRocket StockRocket 6 minutes ago
lmfao 2010-14 yrs ago...NOT sticking up for him...but giving him a chance at these prices to get job done
GMZP
StockRocket StockRocket 6 minutes ago
lmfao 2010-14 yrs ago...NOT sticking up for him...but giving him a chance at these prices to get job done
GMZP
IB_ IB_ 6 minutes ago
LoL LoL, you do realize that your commentary contributes nothing to the board, right ???????????

Seriously, is this the job you always dreamed of ???????? What may I ask is your compensation, $0.05 Per Post ??????????????

IB_🤴🏻
ELTP
Patient Ninja Patient Ninja 6 minutes ago
Ninja has never seen GAHC this active in any price band as this year. Whatever makes it break out soon will send it rocketing to the sky. I'm tipping sometime in the next few months.
GAHC
Bubae Bubae 6 minutes ago
You know what I find interesting is that this Markowski character and Shawn Leon teamed up to super spin projections and none of you long time pumpers are promoting the story line. Those podcasts were so badly done that even you all aren't taking the bait. What they are doing is straight up stock pr
GRST
OMOLIVES OMOLIVES 7 minutes ago
Man...it's killing you...lol. I do get your point though. It seems opposite to what they set out to do. Less is more...and this looks like a confusing run around.
BDEZ BDEZ 8 minutes ago
Add “be able to do a push-up”!
Tomorrowneverknows Tomorrowneverknows 8 minutes ago
Sweeeet
HIRU
BLACKBIRDSR-71 BLACKBIRDSR-71 8 minutes ago
Going BigTime$$$$$$
RNVA
Swampy83 Swampy83 8 minutes ago
Today must be bashing day... always the same 3 clowns.
Shocker!
SMCE
dailyinvestingadvice dailyinvestingadvice 8 minutes ago
Congrats on the gains. I'm holding a few million shares in the Roth and some more I've been accumulating sub penny. I am green again on position after today's move because I have kept my average super duper low (originally bought around .02) and have even averaged down. Some are just so pessimistic
WNFT
Doc logic Doc logic 8 minutes ago
dmb2,

FDA wants all the attention on them and their approval process allows for more subjectivity which creates a target for attempted influence. The UK and EU require more upfront spending and preparation for manufacturing roll out which helps weed out anyone not serious about getti
NWBO
Involuntary-Recluse Involuntary-Recluse 9 minutes ago
R.I.P Bob Newhart and Lou Dobbs 😇😇
Thanks for all the memories...
georgejjl georgejjl 9 minutes ago
Abe,

I am sorry but the Phase2b/3 Alzheimer’s disease treatment trial using blarcamesine did NOT include any patients in Spain.

It included patients in and from Australia, the UK, Canada, the Netherlands and Germany.

There could however have been multiple
AVXL
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved